William Facteau Earlens CEO Rating

Earlens CEO William Facteau Bio

Bill Facteau is a medical device executive with 30 years of experience in the industry. He currently serves on the Boards of Earlens and Aerin Medical. In Nov 2013, Facteau joined Earlens as President & CEO. Prior to Earlens, Facteau held positions as Vice Chairman of ExploraMed and an Entrepreneur in Residence at NEA, respectively. He was Chairman of the Board for Cabochon Aesthetics and a board member at NeoTract and CV Ingenuity prior to their acquisitions.

From 2004-2010, Facteau served as President & CEO of Acclarent. Under his leadership, the company went from concept to acquisition in 5 years, raised over $100M and grew revenues to $100M. After the $800M acquisition by J&J, Mr. Facteau served as WW President of their ENT Division from 2010-2012.

Prior to Acclarent, Facteau was GM of the Endovascular Division at Abbott Vascular. He joined Abbott via the $683 million acquisition of Perclose, where he was Sales Director. From 1993-1998, he worked at US Surgical. Mr. Facteau received his BA in Political Science from the Univ. of Connecticut.

Earlens CEO William Facteau At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Earlens.

Based on 13 ratings, William Facteau ranks right below Sonic Innovations' CEO, Werner Schwendener.

Earlens' CEO is highly regarded by Female employees. Overall, the CEO score has remained stable over the last 90 days.